MetaPlanet

MetaPlanet operates as an evergreen venture capital organization with a streamlined team focused on identifying and supporting early-stage investments in transformative deep technologies. Since its establishment in 2011, the firm has dedicated its resources to backing scientific innovations with potential for multi-generational impact, particularly those addressing humanity's most pressing long-term challenges. Their investment philosophy centers on technologies that could fundamentally alter civilization's trajectory toward a more sustainable and resilient future.

The firm's impressive portfolio has expanded to include over 150 startups across various cutting-edge sectors including artificial intelligence, biotechnology, clean energy, and advanced computing. MetaPlanet distinguishes itself through its science-first approach, prioritizing ventures with robust technological foundations rather than merely trending market opportunities. This strategy has yielded remarkable results, with the firm successfully navigating more than 50 profitable exits, demonstrating both the viability and financial potential of deep tech investments.

Beyond commercial ventures, MetaPlanet allocates significant resources to non-commercial research initiatives specifically targeting existential risk reduction. The firm has become a notable supporter of responsible AI development, funding projects that explore safety mechanisms, alignment strategies, and ethical frameworks for advanced artificial intelligence systems. This dual investment approach - supporting both commercial innovation and foundational safety research - positions MetaPlanet at the intersection of technological progress and humanitarian responsibility.

As an evergreen fund without traditional limited partner constraints, MetaPlanet enjoys exceptional flexibility in its investment horizons, allowing it to support technologies with longer development timelines that might be overlooked by conventional venture capital. The firm typically engages at seed and Series A stages, though it maintains capacity for follow-on investments in portfolio companies demonstrating exceptional promise. MetaPlanet's patient capital model has proven particularly valuable in deep tech domains where scientific breakthroughs often require sustained support before commercial applications emerge. This distinctive approach has established the firm as a trusted partner for visionary founders working on humanity's most consequential technological frontiers.